Benzinga's Volume Movers

Intercept Pharmaceuticals ICPT shares moved up 258.85% to $259.77. The volume of Intercept Pharmaceuticals shares traded was 1094% higher than normal. Intercept reported that the FLINT trial of obeticholic acid has been stopped early and the NASH primary endpoint has been met. GW Pharmaceuticals plc GWPH shares rose 7.70% to $40.99. The volume of GW Pharmaceuticals shares traded was 1000% higher than normal. GW Pharma priced follow on offering of 2,441,110 ADSs at $36.00 per ADS. Receptos RCPT shares climbed 7.83% to $34.00. The volume of Receptos shares traded was 909% higher than normal. Receptos priced 3.32 million shares of common stock at $30.75 per share. Sangamo Biosciences SGMO surged 25.01% to $17.06. The volume of Sangamo Biosciences shares traded was 546% higher than normal. Sangamo and Biogen Idec BIIB announced the global collaboration to develop treatments for hemoglobinopathies.